GW&K Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

GW&K Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-169,553	Closed	-$4.05M	–	400
2019 Q4	$4.05M	Sell	169,553 -8,216	-5%	-$227K	0.05%	262
2019 Q3	$4.77M	Buy	177,769 +52,248	+42%	+$1.47M	0.07%	242
2019 Q2	$3.4M	Sell	125,521 -1,280	-1%	-$40.1K	0.05%	264
2019 Q1	$4.4M	Sell	126,801 -10,739	-8%	-$310K	0.07%	226
2018 Q4	$2.69M	Sell	137,540 -16,296	-11%	-$335K	0.05%	220
2018 Q3	$4.1M	Sell	153,836 -1,481	-1%	-$48.4K	0.07%	216
2018 Q2	$5.87M	Buy	155,317 +43,709	+39%	+$1.67M	0.1%	207
2018 Q1	$3.65M	Buy	111,608 +20,206	+22%	+$887K	0.06%	218
2017 Q4	$4.45M	Buy	+91,402	New	+$4.62M	0.08%	205

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

GW&K Investment Management's PTLA Position: Q1 2020 in Review

GW&K Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 169,553 shares — an estimated $4.05M sold.

GW&K Investment Management first reported a position in PTLA in Q4 2017 and held it in 9 quarters. The position peaked at $5.87M in Q2 2018. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

GW&K Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
GW&K Investment Management sold 169,553 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $4.05M.
GW&K Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 9 quarters.
GW&K Investment Management's Portola Pharmaceuticals, Inc. position peaked at $5.87M in Q2 2018.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on GW&K Investment Management's 13F filing for Q1 2020, filed 11 May 2020.